Report overview
Paediatric respiratory medicine (PRM) is a multidisciplinary subspecialty within the specialty of paediatrics, involving doctors, nurses, respiratory physiologists, physiotherapists, the child and the parent/caregiver.
This report contains market size and forecasts of Pediatrics Respiratory Drugs in global, including the following market information:
Global Pediatrics Respiratory Drugs Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Pediatrics Respiratory Drugs Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Pediatrics Respiratory Drugs companies in 2021 (%)
The global Pediatrics Respiratory Drugs market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Powder Inhalation Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Pediatrics Respiratory Drugs include Mylan, Armstrong Pharmaceuticals, GlaxoSmithKline, Valeant Pharmaceuticals, Merck, Endo International, Bauch & Lomb and Boehringer Ingelheim, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Pediatrics Respiratory Drugs manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Pediatrics Respiratory Drugs Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Type, 2021 (%)
Powder Inhalation
Oral
Global Pediatrics Respiratory Drugs Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Others
Global Pediatrics Respiratory Drugs Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Pediatrics Respiratory Drugs Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Pediatrics Respiratory Drugs revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Pediatrics Respiratory Drugs revenues share in global market, 2021 (%)
Key companies Pediatrics Respiratory Drugs sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Pediatrics Respiratory Drugs sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Mylan
Armstrong Pharmaceuticals
GlaxoSmithKline
Valeant Pharmaceuticals
Merck
Endo International
Bauch & Lomb
Boehringer Ingelheim
